Parecoxib (parecoxib sodium)

Drugs

Volumn 61, Issue 8, 2001, Pages 1133-1141

  Cheer, S M ^a   Goa, K L ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; KETOROLAC; MORPHINE; PARECOXIB; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC SURGERY; HEADACHE; HUMAN; NAUSEA; ORTHOPEDIC SURGERY; OSTEITIS; PAIN; POSTOPERATIVE PAIN; REVIEW; STOMACH EROSION; STOMACH ULCER; TOOTH PAIN; VERTIGO;

EID: 0034944053     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200161080-00010     Document Type: Review

References (26)

1. Acute pain
2. Evaluation of intravenous parecoxib for the relief of acute post-surgical pain
3. Adverse effects of nonsteroidal anti-inflannatory drugs on the gastrointestinal system
4. Scientific rationale for specific inhibition of COX-2
5. The discovery and function of COX-2
6. Intravenous analgesia
7. N-[[(5-Methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration
8. A comparative analgesic efficacy study of parecoxib, a new COX-2 specific inhibitor, in post-gynecological surgery patients
9. Effect of parecoxib, a new cyclooxygenase-2 inhibitor, on the postoperative analgesia
10. Analgesic activity and safety of parecoxib in post-surgical patients: An interim report
11. Evaluation of the opiod-sparing effectiveness of parecoxib sodium, a new COX-2 specific inhibitor, in the management of postoperative pain following total hip arthroplasty
12. A comparative analgesic efficacy study of parecoxib sodium, a new injectable COX-2 inhibitor, in post-orthopedic surgery patients
13. An endoscopic study of the gastroduodenal effects of SC-69124A, a parenteral COX-2-specific inhibitor, in the elderly
14. An endoscopic study of the gastroduodenal effects of parecoxib sodium, an injectable COX-2 inhibitor in the elderly
15. Parecoxib sodium, an injectable COX-2 specific inhibitor, does not affect aspirin-mediated platelet function
16. Parecoxib sodium, an injectable COX-2 specific inhibitor, does not affect heparin-regulated blood coagulation parameters
17. A safety and pharmacokinetic study of analgesic doses of parecoxib sodium, a new COX-2 specific inhibitor, in healthy subjects
18. Single dose tolerability and pharmacokinetics of parecoxib sodium, a COX-2 specific inhibitor, following intravenous administration
19. Effects of parecoxib, a parenteral COX-2 specific inhibitor, on the disposition of midazolam
20. Evaluation of parecoxib, a new injectable cyclooxygenase-2-specific inhibitor, for the treatment of pain
21. Effects of parecoxib, a parenteral COX-2 specific inhibitor, on the disposition of propofol